
Ankur Sood
About Ankur Sood
Data last updated:
Ankur Sood is a Director at Span Minerals Private Limited (since 2020), Designated Partner at Miso Consulting Llp (since 2017) and Designated Partner at Rejiva Therapeutics Llp (since 2016). The companies operate in Metals and Minerals, Service and Healthcare. The largest current company by reported revenue is Span Minerals Private Limited at ₹6.92 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jan 2020 | 2017 | ₹6.92 Cr (FY 2025) | Active | |
| Designated Partner | 11 Jan 2017 | 2017 | Active | ||
| Designated Partner | 27 May 2016 | 2016 | Active |
Board colleagues of Ankur Sood
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanjay Kumar Mittal | 01075711 | Span Minerals Private Limited | Director |
| Pragya Mishra | 07519350 | Miso Consulting Llp , Rejiva Therapeutics Llp | Designated Partner |
| Brijendra Kumar Sood | 06857041 | Rejiva Therapeutics Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankur Sood
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankur Sood
Ankur Sood currently holds 3 directorships: Span Minerals Private Limited (Director, since 22 Jan 2020, revenue ₹6.92 Cr (FY 2025)); Miso Consulting Llp (Designated Partner, since 11 Jan 2017); Rejiva Therapeutics Llp (Designated Partner, since 27 May 2016).
Ankur Sood was first appointed on 27 May 2016 as Designated Partner at Rejiva Therapeutics Llp. The most recent appointment on record is 22 Jan 2020 at Span Minerals Private Limited.
The current boards of Ankur Sood's companies include Sanjay Kumar Mittal (Span Minerals Private Limited), Pragya Mishra (Miso Consulting Llp), Brijendra Kumar Sood (Rejiva Therapeutics Llp).